Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02533115 |
| Title | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML |
| Acronym | 401 |
| Recruitment | Approved for marketing |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Celator Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior |
| Covered Countries | USA |